

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | angiotensin maturation (GO:0002003) | 9.57384603 |
| 2 | regulation of guanylate cyclase activity (GO:0031282) | 7.88519309 |
| 3 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 7.49656952 |
| 4 | intestinal absorption (GO:0050892) | 7.29822119 |
| 5 | central nervous system myelination (GO:0022010) | 7.20947099 |
| 6 | axon ensheathment in central nervous system (GO:0032291) | 7.20947099 |
| 7 | regulation of bile acid biosynthetic process (GO:0070857) | 6.64186471 |
| 8 | positive regulation of guanylate cyclase activity (GO:0031284) | 6.04563240 |
| 9 | epoxygenase P450 pathway (GO:0019373) | 5.80888770 |
| 10 | NADH metabolic process (GO:0006734) | 5.49596039 |
| 11 | fat-soluble vitamin biosynthetic process (GO:0042362) | 5.47886408 |
| 12 | lipoprotein transport (GO:0042953) | 5.40777875 |
| 13 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 5.26761395 |
| 14 | endocrine process (GO:0050886) | 5.26761395 |
| 15 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 5.26761395 |
| 16 | cellular glucuronidation (GO:0052695) | 5.19494144 |
| 17 | glucuronate metabolic process (GO:0019585) | 5.17932641 |
| 18 | uronic acid metabolic process (GO:0006063) | 5.17932641 |
| 19 | regulation of systemic arterial blood pressure (GO:0003073) | 4.97458335 |
| 20 | regulation of cGMP biosynthetic process (GO:0030826) | 4.78083923 |
| 21 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 4.71484842 |
| 22 | hormone catabolic process (GO:0042447) | 4.69610388 |
| 23 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 4.63883183 |
| 24 | renal system process involved in regulation of blood volume (GO:0001977) | 4.61041732 |
| 25 | drug metabolic process (GO:0017144) | 4.56344978 |
| 26 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 4.56183298 |
| 27 | sulfate transmembrane transport (GO:1902358) | 4.54434623 |
| 28 | auditory receptor cell differentiation (GO:0042491) | 4.51852687 |
| 29 | synaptic vesicle maturation (GO:0016188) | 4.49487896 |
| 30 | digestion (GO:0007586) | 4.48661999 |
| 31 | maintenance of gastrointestinal epithelium (GO:0030277) | 4.44930659 |
| 32 | transcytosis (GO:0045056) | 4.38315980 |
| 33 | regulation of cellular extravasation (GO:0002691) | 4.29466713 |
| 34 | positive regulation of respiratory burst (GO:0060267) | 4.24091280 |
| 35 | bile acid and bile salt transport (GO:0015721) | 4.21455544 |
| 36 | vitamin transmembrane transport (GO:0035461) | 4.20713563 |
| 37 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 4.16865018 |
| 38 | peptide hormone processing (GO:0016486) | 4.13916028 |
| 39 | neuronal action potential propagation (GO:0019227) | 4.13068259 |
| 40 | flavonoid metabolic process (GO:0009812) | 4.12902080 |
| 41 | fructose metabolic process (GO:0006000) | 4.08743011 |
| 42 | L-amino acid import (GO:0043092) | 4.07298313 |
| 43 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.05011294 |
| 44 | regulation of cGMP metabolic process (GO:0030823) | 4.04263492 |
| 45 | O-glycan processing (GO:0016266) | 4.02470320 |
| 46 | diacylglycerol metabolic process (GO:0046339) | 4.02338520 |
| 47 | positive regulation of glycoprotein metabolic process (GO:1903020) | 3.99554645 |
| 48 | vitamin A metabolic process (GO:0006776) | 3.99235215 |
| 49 | glycine transport (GO:0015816) | 3.96831314 |
| 50 | kidney morphogenesis (GO:0060993) | 3.85493023 |
| 51 | homocysteine metabolic process (GO:0050667) | 3.80543830 |
| 52 | axon ensheathment (GO:0008366) | 3.78974575 |
| 53 | ensheathment of neurons (GO:0007272) | 3.78974575 |
| 54 | negative regulation of gene silencing (GO:0060969) | 3.78163641 |
| 55 | locomotory exploration behavior (GO:0035641) | 3.78017470 |
| 56 | myelination (GO:0042552) | 3.76769706 |
| 57 | positive regulation of pseudopodium assembly (GO:0031274) | 3.74681863 |
| 58 | arginine metabolic process (GO:0006525) | 3.73095608 |
| 59 | sulfate transport (GO:0008272) | 3.70470078 |
| 60 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.69677702 |
| 61 | drug catabolic process (GO:0042737) | 3.67006706 |
| 62 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.66845842 |
| 63 | digestive system process (GO:0022600) | 3.66711566 |
| 64 | antibacterial humoral response (GO:0019731) | 3.65406853 |
| 65 | negative regulation of neurotransmitter transport (GO:0051589) | 3.65248280 |
| 66 | synaptic vesicle exocytosis (GO:0016079) | 3.63724905 |
| 67 | urea cycle (GO:0000050) | 3.61038817 |
| 68 | fatty acid elongation (GO:0030497) | 3.60336603 |
| 69 | vitamin transport (GO:0051180) | 3.59213247 |
| 70 | peptide catabolic process (GO:0043171) | 3.58904647 |
| 71 | virion attachment to host cell (GO:0019062) | 3.58637100 |
| 72 | adhesion of symbiont to host cell (GO:0044650) | 3.58637100 |
| 73 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.58226942 |
| 74 | cellular potassium ion homeostasis (GO:0030007) | 3.53144755 |
| 75 | myelin maintenance (GO:0043217) | 3.51265219 |
| 76 | alkaloid metabolic process (GO:0009820) | 3.50509519 |
| 77 | sulfur compound transport (GO:0072348) | 3.49976280 |
| 78 | epithelial structure maintenance (GO:0010669) | 3.49846599 |
| 79 | positive regulation of cGMP biosynthetic process (GO:0030828) | 3.48419915 |
| 80 | antimicrobial humoral response (GO:0019730) | 3.48386277 |
| 81 | neuron cell-cell adhesion (GO:0007158) | 3.48241525 |
| 82 | vocalization behavior (GO:0071625) | 3.46035341 |
| 83 | long-chain fatty acid biosynthetic process (GO:0042759) | 3.46029778 |
| 84 | oligosaccharide biosynthetic process (GO:0009312) | 3.41241947 |
| 85 | urea metabolic process (GO:0019627) | 3.40637417 |
| 86 | intestinal epithelial cell development (GO:0060576) | 3.39998500 |
| 87 | exogenous drug catabolic process (GO:0042738) | 3.38556099 |
| 88 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.38192407 |
| 89 | negative regulation of neurotransmitter secretion (GO:0046929) | 3.38073553 |
| 90 | fat-soluble vitamin metabolic process (GO:0006775) | 3.36693177 |
| 91 | vitamin biosynthetic process (GO:0009110) | 3.33912261 |
| 92 | glycerol metabolic process (GO:0006071) | 3.32887694 |
| 93 | sphingomyelin metabolic process (GO:0006684) | 3.31950729 |
| 94 | regulation of pseudopodium assembly (GO:0031272) | 3.29473347 |
| 95 | response to hepatocyte growth factor (GO:0035728) | 3.29369652 |
| 96 | cellular response to hepatocyte growth factor stimulus (GO:0035729) | 3.29369652 |
| 97 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 3.28794340 |
| 98 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 3.28794340 |
| 99 | regulation of vitamin metabolic process (GO:0030656) | 3.27466255 |
| 100 | potassium ion import (GO:0010107) | 3.27297436 |
| 101 | regulation of triglyceride catabolic process (GO:0010896) | 3.26264835 |
| 102 | cobalamin metabolic process (GO:0009235) | 3.25855080 |
| 103 | adult walking behavior (GO:0007628) | 3.25197715 |
| 104 | cellular response to nitric oxide (GO:0071732) | 3.25168951 |
| 105 | glomerulus development (GO:0032835) | 3.25057628 |
| 106 | sulfation (GO:0051923) | 3.24186428 |
| 107 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.23184159 |
| 108 | cGMP-mediated signaling (GO:0019934) | 3.22458978 |
| 109 | glutamate secretion (GO:0014047) | 3.18916017 |
| 110 | response to histamine (GO:0034776) | 3.18237640 |
| 111 | transepithelial transport (GO:0070633) | 3.17609767 |
| 112 | potassium ion homeostasis (GO:0055075) | 3.17512082 |
| 113 | sodium ion homeostasis (GO:0055078) | 3.16251315 |
| 114 | neuromuscular process controlling posture (GO:0050884) | 3.15985246 |
| 115 | drinking behavior (GO:0042756) | 3.15741739 |
| 116 | cGMP biosynthetic process (GO:0006182) | 3.15447175 |
| 117 | regulation of synaptic vesicle transport (GO:1902803) | 3.14850152 |
| 118 | sodium ion export (GO:0071436) | 3.12702480 |
| 119 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 3.11165575 |
| 120 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.10660628 |
| 121 | renal system process involved in regulation of systemic arterial blood pressure (GO:0003071) | 3.09980749 |
| 122 | bile acid metabolic process (GO:0008206) | 3.09347068 |
| 123 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.09204060 |
| 124 | regulation of cholesterol homeostasis (GO:2000188) | 3.07568893 |
| 125 | neurotransmitter secretion (GO:0007269) | 3.07514102 |
| 126 | drug transmembrane transport (GO:0006855) | 3.07497036 |
| 127 | amino acid import (GO:0043090) | 3.06915919 |
| 128 | presynaptic membrane organization (GO:0097090) | 3.06728493 |
| 129 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.06124612 |
| 130 | citrulline biosynthetic process (GO:0019240) | 3.04960203 |
| 131 | gamma-aminobutyric acid transport (GO:0015812) | 3.03505328 |
| 132 | positive regulation of cGMP metabolic process (GO:0030825) | 3.03459239 |
| 133 | transmission of nerve impulse (GO:0019226) | 3.03118136 |
| 134 | regulation of protein glycosylation (GO:0060049) | 3.02458796 |
| 135 | midgut development (GO:0007494) | 2.99902075 |
| 136 | glomerular filtration (GO:0003094) | 2.99275184 |
| 137 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.98746111 |
| 138 | citrulline metabolic process (GO:0000052) | 2.98745741 |
| 139 | glutamine family amino acid biosynthetic process (GO:0009084) | 2.98550120 |
| 140 | response to methylmercury (GO:0051597) | 2.98404829 |
| 141 | auditory behavior (GO:0031223) | 2.97275768 |
| 142 | neurotransmitter transport (GO:0006836) | 2.95159745 |
| 143 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.94214476 |
| 144 | positive regulation of membrane potential (GO:0045838) | 2.93371631 |
| 145 | neuron-neuron synaptic transmission (GO:0007270) | 2.91348967 |
| 146 | membrane hyperpolarization (GO:0060081) | 2.89985100 |
| 147 | dendritic spine morphogenesis (GO:0060997) | 2.89702680 |
| 148 | mechanosensory behavior (GO:0007638) | 2.87871366 |
| 149 | establishment of mitochondrion localization (GO:0051654) | 2.84779061 |
| 150 | regulation of synapse structural plasticity (GO:0051823) | 2.84585011 |
| 151 | neurotransmitter uptake (GO:0001504) | 2.84516833 |
| 152 | negative regulation of protein localization to cell surface (GO:2000009) | 2.83544354 |
| 153 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.83322353 |
| 154 | regulation of beta-amyloid formation (GO:1902003) | 2.83238071 |
| 155 | neuronal ion channel clustering (GO:0045161) | 2.82041540 |
| 156 | neuromuscular process controlling balance (GO:0050885) | 2.81643590 |
| 157 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.79525561 |
| 158 | nerve growth factor signaling pathway (GO:0038180) | 2.78940262 |
| 159 | glutamate receptor signaling pathway (GO:0007215) | 2.78521972 |
| 160 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.76951307 |
| 161 | neuron recognition (GO:0008038) | 2.76686336 |
| 162 | synaptic transmission, glutamatergic (GO:0035249) | 2.75518969 |
| 163 | long-term memory (GO:0007616) | 2.74531342 |
| 164 | presynaptic membrane assembly (GO:0097105) | 2.74507225 |
| 165 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.74392567 |
| 166 | long-term synaptic potentiation (GO:0060291) | 2.74217152 |
| 167 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.72513634 |
| 168 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.70375964 |
| 169 | response to auditory stimulus (GO:0010996) | 2.69974804 |
| 170 | positive regulation of potassium ion transport (GO:0043268) | 2.68531478 |
| 171 | regulation of neurotransmitter levels (GO:0001505) | 2.67212244 |
| 172 | glycosylceramide metabolic process (GO:0006677) | 2.66667020 |
| 173 | exploration behavior (GO:0035640) | 2.66645852 |
| 174 | regulation of synaptic plasticity (GO:0048167) | 2.66399331 |
| 175 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.65521159 |
| 176 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.63217811 |
| 177 | protein localization to synapse (GO:0035418) | 2.62287228 |
| 178 | apical protein localization (GO:0045176) | 2.61916616 |
| 179 | mating behavior (GO:0007617) | 2.61052692 |
| 180 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.60896109 |
| 181 | oligodendrocyte differentiation (GO:0048709) | 2.58945852 |
| 182 | adenosine receptor signaling pathway (GO:0001973) | 2.58939821 |
| 183 | magnesium ion transport (GO:0015693) | 2.58914936 |
| 184 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.54474680 |
| 185 | positive regulation of epidermal growth factor-activated receptor activity (GO:0045741) | 2.54389839 |
| 186 | regulation of neurotransmitter uptake (GO:0051580) | 2.53237447 |
| 187 | cerebellar Purkinje cell layer development (GO:0021680) | 2.52964628 |
| 188 | axonal fasciculation (GO:0007413) | 2.49363910 |
| 189 | layer formation in cerebral cortex (GO:0021819) | 2.48325590 |
| 190 | asymmetric protein localization (GO:0008105) | 2.47186605 |
| 191 | prepulse inhibition (GO:0060134) | 2.46423319 |
| 192 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.46354105 |
| 193 | neuromuscular process (GO:0050905) | 2.43657160 |
| 194 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.43470514 |
| 195 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.43169035 |
| 196 | cyclic nucleotide catabolic process (GO:0009214) | 2.43077156 |
| 197 | substrate-independent telencephalic tangential interneuron migration (GO:0021843) | 2.42448033 |
| 198 | substrate-independent telencephalic tangential migration (GO:0021826) | 2.42448033 |
| 199 | activation of protein kinase A activity (GO:0034199) | 2.41355323 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 5.69563555 |
| 2 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.06567386 |
| 3 | GATA4_25053715_ChIP-Seq_YYC3_Human | 3.18364377 |
| 4 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 3.17948312 |
| 5 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 3.08586553 |
| 6 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.92063241 |
| 7 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.81060535 |
| 8 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.78799489 |
| 9 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.73914280 |
| 10 | GATA6_25053715_ChIP-Seq_YYC3_Human | 2.71800444 |
| 11 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.48520216 |
| 12 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.42564407 |
| 13 | * FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 2.42279288 |
| 14 | SOX2_20726797_ChIP-Seq_SW620_Human | 2.41686903 |
| 15 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.37196545 |
| 16 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.36345606 |
| 17 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.32864927 |
| 18 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.32021735 |
| 19 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.32021735 |
| 20 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.31448785 |
| 21 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.27833075 |
| 22 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.27224367 |
| 23 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 2.11711252 |
| 24 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.11435213 |
| 25 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.06429192 |
| 26 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.06054425 |
| 27 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.04181946 |
| 28 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.02632086 |
| 29 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 2.00812439 |
| 30 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.94796413 |
| 31 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.94745677 |
| 32 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.91248979 |
| 33 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.88999699 |
| 34 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.83739018 |
| 35 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.83461152 |
| 36 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.82895667 |
| 37 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.76835688 |
| 38 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.75808118 |
| 39 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.75128793 |
| 40 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.74547678 |
| 41 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.69638618 |
| 42 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.69478362 |
| 43 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.67552679 |
| 44 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.64432542 |
| 45 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.64258232 |
| 46 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.64166043 |
| 47 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.53980505 |
| 48 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.52804599 |
| 49 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.48811098 |
| 50 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.48119886 |
| 51 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.46889104 |
| 52 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.45066407 |
| 53 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.44554551 |
| 54 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.42237371 |
| 55 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.40897077 |
| 56 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.39592222 |
| 57 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.39417332 |
| 58 | VDR_22108803_ChIP-Seq_LS180_Human | 1.39262687 |
| 59 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.36275429 |
| 60 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.36162570 |
| 61 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.35262339 |
| 62 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.35045634 |
| 63 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.34907818 |
| 64 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.34087955 |
| 65 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.33442834 |
| 66 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 1.33346798 |
| 67 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.32260019 |
| 68 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.31648997 |
| 69 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.31505399 |
| 70 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.30984694 |
| 71 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.30251042 |
| 72 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.29055130 |
| 73 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.27749209 |
| 74 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.27569572 |
| 75 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.27186068 |
| 76 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.26325319 |
| 77 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.26238686 |
| 78 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.26213893 |
| 79 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.25820082 |
| 80 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.25679776 |
| 81 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.24356696 |
| 82 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.24280638 |
| 83 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 1.23341353 |
| 84 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.21759401 |
| 85 | STAT3_23295773_ChIP-Seq_U87_Human | 1.21587090 |
| 86 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.21478692 |
| 87 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.20303583 |
| 88 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.19852107 |
| 89 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.19422993 |
| 90 | * CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.19318011 |
| 91 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.19281700 |
| 92 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.17976749 |
| 93 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.17846985 |
| 94 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.17750505 |
| 95 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.14856805 |
| 96 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 1.13866457 |
| 97 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.13814785 |
| 98 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 1.13442274 |
| 99 | P300_19829295_ChIP-Seq_ESCs_Human | 1.12805858 |
| 100 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.09192289 |
| 101 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.08981518 |
| 102 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.08277813 |
| 103 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.07550924 |
| 104 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.07520525 |
| 105 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.07423781 |
| 106 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.07357350 |
| 107 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.07017805 |
| 108 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.05773838 |
| 109 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.05183883 |
| 110 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.03799061 |
| 111 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 1.03256578 |
| 112 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.02809219 |
| 113 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.02472351 |
| 114 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 1.02102795 |
| 115 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 1.01902828 |
| 116 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.01480306 |
| 117 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.01285414 |
| 118 | AR_25329375_ChIP-Seq_VCAP_Human | 1.01211970 |
| 119 | POU5F1_18347094_ChIP-ChIP_MESCs_Mouse | 1.00999748 |
| 120 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.00989838 |
| 121 | CEBPB_22108803_ChIP-Seq_LS180_Human | 1.00562208 |
| 122 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.00314520 |
| 123 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.99851490 |
| 124 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.99654891 |
| 125 | NANOG_18347094_ChIP-ChIP_MESCs_Mouse | 0.99513957 |
| 126 | * TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.99362635 |
| 127 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.99190238 |
| 128 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.99103791 |
| 129 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 0.98756389 |
| 130 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.98515439 |
| 131 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.98486522 |
| 132 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.97859212 |
| 133 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.97371404 |
| 134 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.97191676 |
| 135 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.97191676 |
| 136 | PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 0.96516736 |
| 137 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.96417814 |
| 138 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 0.95794015 |
| 139 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 0.95794015 |
| 140 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.95794015 |
| 141 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.95756621 |
| 142 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.95756621 |
| 143 | FUS_26573619_Chip-Seq_HEK293_Human | 0.95670596 |
| 144 | TCF4_23295773_ChIP-Seq_U87_Human | 0.95167097 |
| 145 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 0.95081172 |
| 146 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.94960007 |
| 147 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.94654414 |
| 148 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.94597184 |
| 149 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.94418162 |
| 150 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.93600609 |
| 151 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.92636373 |
| 152 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.92334707 |
| 153 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.91909684 |
| 154 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.91558075 |
| 155 | AR_19668381_ChIP-Seq_PC3_Human | 0.91380190 |
| 156 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 0.91143381 |
| 157 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.90795724 |
| 158 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.90449303 |
| 159 | * ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.90215879 |
| 160 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.89986793 |
| 161 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.89983091 |
| 162 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.89718518 |
| 163 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.88478681 |
| 164 | RXR_22108803_ChIP-Seq_LS180_Human | 0.88367784 |
| 165 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.88163594 |
| 166 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 0.87351173 |
| 167 | * SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.86931615 |
| 168 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.85938246 |
| 169 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 0.85744301 |
| 170 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.85735631 |
| 171 | KDM2B_26808549_Chip-Seq_K562_Human | 0.85713796 |
| 172 | NFYA_21822215_ChIP-Seq_K562_Human | 0.85587461 |
| 173 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.85105868 |
| 174 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.84754153 |
| 175 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.83394826 |
| 176 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.83253301 |
| 177 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.83123844 |
| 178 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.82711930 |
| 179 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.81913504 |
| 180 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.81367449 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 7.06500982 |
| 2 | MP0004859_abnormal_synaptic_plasticity | 4.60323172 |
| 3 | MP0001666_abnormal_nutrient_absorption | 4.47762743 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 4.43233627 |
| 5 | MP0003880_abnormal_central_pattern | 4.30037776 |
| 6 | MP0002139_abnormal_hepatobiliary_system | 3.67565191 |
| 7 | MP0009379_abnormal_foot_pigmentation | 3.63155076 |
| 8 | MP0004270_analgesia | 3.50126597 |
| 9 | MP0005365_abnormal_bile_salt | 3.45449089 |
| 10 | MP0004147_increased_porphyrin_level | 3.42679073 |
| 11 | MP0004019_abnormal_vitamin_homeostasis | 3.39767396 |
| 12 | MP0002822_catalepsy | 3.39508145 |
| 13 | MP0003635_abnormal_synaptic_transmissio | 3.24907204 |
| 14 | MP0000920_abnormal_myelination | 3.06421153 |
| 15 | MP0002064_seizures | 2.97957749 |
| 16 | MP0002272_abnormal_nervous_system | 2.87113658 |
| 17 | MP0009745_abnormal_behavioral_response | 2.82283452 |
| 18 | MP0001486_abnormal_startle_reflex | 2.77295729 |
| 19 | MP0010352_gastrointestinal_tract_polyps | 2.66034668 |
| 20 | MP0004043_abnormal_pH_regulation | 2.62569511 |
| 21 | MP0002063_abnormal_learning/memory/cond | 2.54717899 |
| 22 | MP0003329_amyloid_beta_deposits | 2.54585996 |
| 23 | MP0009046_muscle_twitch | 2.50379933 |
| 24 | MP0001188_hyperpigmentation | 2.45560317 |
| 25 | MP0004885_abnormal_endolymph | 2.41745011 |
| 26 | MP0005423_abnormal_somatic_nervous | 2.31866716 |
| 27 | MP0002734_abnormal_mechanical_nocicepti | 2.31854209 |
| 28 | MP0003690_abnormal_glial_cell | 2.29773091 |
| 29 | MP0002572_abnormal_emotion/affect_behav | 2.27379068 |
| 30 | MP0001529_abnormal_vocalization | 2.27192893 |
| 31 | MP0001501_abnormal_sleep_pattern | 2.04619965 |
| 32 | MP0010155_abnormal_intestine_physiology | 1.99567593 |
| 33 | MP0000490_abnormal_crypts_of | 1.98912880 |
| 34 | MP0004142_abnormal_muscle_tone | 1.95545303 |
| 35 | MP0008569_lethality_at_weaning | 1.89137905 |
| 36 | MP0000013_abnormal_adipose_tissue | 1.88576944 |
| 37 | MP0000477_abnormal_intestine_morphology | 1.87433666 |
| 38 | MP0001970_abnormal_pain_threshold | 1.87293274 |
| 39 | MP0001440_abnormal_grooming_behavior | 1.85671609 |
| 40 | MP0002254_reproductive_system_inflammat | 1.85514953 |
| 41 | MP0009840_abnormal_foam_cell | 1.85071090 |
| 42 | MP0000538_abnormal_urinary_bladder | 1.84424361 |
| 43 | MP0003718_maternal_effect | 1.84002705 |
| 44 | MP0003868_abnormal_feces_composition | 1.82381969 |
| 45 | MP0000566_synostosis | 1.79942348 |
| 46 | MP0002909_abnormal_adrenal_gland | 1.79033585 |
| 47 | MP0001968_abnormal_touch/_nociception | 1.77147933 |
| 48 | MP0002733_abnormal_thermal_nociception | 1.75542505 |
| 49 | MP0010329_abnormal_lipoprotein_level | 1.72386288 |
| 50 | MP0000537_abnormal_urethra_morphology | 1.71251933 |
| 51 | MP0005332_abnormal_amino_acid | 1.68640121 |
| 52 | MP0003633_abnormal_nervous_system | 1.66670675 |
| 53 | MP0009780_abnormal_chondrocyte_physiolo | 1.65343954 |
| 54 | MP0004742_abnormal_vestibular_system | 1.62891868 |
| 55 | MP0005645_abnormal_hypothalamus_physiol | 1.61381070 |
| 56 | MP0002067_abnormal_sensory_capabilities | 1.59405056 |
| 57 | MP0005646_abnormal_pituitary_gland | 1.56574652 |
| 58 | MP0001905_abnormal_dopamine_level | 1.55210345 |
| 59 | MP0009643_abnormal_urine_homeostasis | 1.54381001 |
| 60 | MP0001502_abnormal_circadian_rhythm | 1.53137008 |
| 61 | MP0003634_abnormal_glial_cell | 1.51361079 |
| 62 | MP0004782_abnormal_surfactant_physiolog | 1.50214379 |
| 63 | MP0000778_abnormal_nervous_system | 1.49713947 |
| 64 | MP0002229_neurodegeneration | 1.48252251 |
| 65 | MP0005386_behavior/neurological_phenoty | 1.45644616 |
| 66 | MP0004924_abnormal_behavior | 1.45644616 |
| 67 | MP0000955_abnormal_spinal_cord | 1.45444691 |
| 68 | MP0005670_abnormal_white_adipose | 1.45331771 |
| 69 | MP0005636_abnormal_mineral_homeostasis | 1.43291193 |
| 70 | MP0003631_nervous_system_phenotype | 1.43154935 |
| 71 | MP0001485_abnormal_pinna_reflex | 1.40622782 |
| 72 | MP0002066_abnormal_motor_capabilities/c | 1.38818793 |
| 73 | MP0000678_abnormal_parathyroid_gland | 1.36846002 |
| 74 | MP0000604_amyloidosis | 1.33778625 |
| 75 | MP0002796_impaired_skin_barrier | 1.33053911 |
| 76 | MP0002557_abnormal_social/conspecific_i | 1.32542649 |
| 77 | MP0001663_abnormal_digestive_system | 1.31098974 |
| 78 | MP0002736_abnormal_nociception_after | 1.30573312 |
| 79 | MP0002735_abnormal_chemical_nociception | 1.25189673 |
| 80 | MP0001764_abnormal_homeostasis | 1.25106755 |
| 81 | MP0005171_absent_coat_pigmentation | 1.24924205 |
| 82 | MP0002882_abnormal_neuron_morphology | 1.24309050 |
| 83 | MP0003183_abnormal_peptide_metabolism | 1.23588142 |
| 84 | MP0003693_abnormal_embryo_hatching | 1.22458749 |
| 85 | MP0003941_abnormal_skin_development | 1.22380488 |
| 86 | MP0001873_stomach_inflammation | 1.21136573 |
| 87 | MP0003632_abnormal_nervous_system | 1.20837643 |
| 88 | MP0005381_digestive/alimentary_phenotyp | 1.19764824 |
| 89 | MP0004811_abnormal_neuron_physiology | 1.17906800 |
| 90 | MP0001765_abnormal_ion_homeostasis | 1.17846327 |
| 91 | MP0001664_abnormal_digestion | 1.16973113 |
| 92 | MP0003252_abnormal_bile_duct | 1.16216959 |
| 93 | MP0000230_abnormal_systemic_arterial | 1.14935384 |
| 94 | MP0000462_abnormal_digestive_system | 1.14918198 |
| 95 | MP0002098_abnormal_vibrissa_morphology | 1.14469657 |
| 96 | MP0003283_abnormal_digestive_organ | 1.12975546 |
| 97 | MP0003879_abnormal_hair_cell | 1.12488929 |
| 98 | MP0005058_abnormal_lysosome_morphology | 1.09482608 |
| 99 | MP0001963_abnormal_hearing_physiology | 1.07632566 |
| 100 | MP0003075_altered_response_to | 1.05961676 |
| 101 | MP0005409_darkened_coat_color | 1.05576456 |
| 102 | MP0002184_abnormal_innervation | 1.03641302 |
| 103 | MP0000003_abnormal_adipose_tissue | 1.02300981 |
| 104 | MP0002136_abnormal_kidney_physiology | 1.02049255 |
| 105 | MP0003172_abnormal_lysosome_physiology | 1.01336487 |
| 106 | MP0004858_abnormal_nervous_system | 1.00030861 |
| 107 | MP0005167_abnormal_blood-brain_barrier | 0.99331646 |
| 108 | MP0002138_abnormal_hepatobiliary_system | 0.97979505 |
| 109 | MP0001756_abnormal_urination | 0.97793717 |
| 110 | MP0003950_abnormal_plasma_membrane | 0.97709079 |
| 111 | MP0005551_abnormal_eye_electrophysiolog | 0.97695217 |
| 112 | MP0010234_abnormal_vibrissa_follicle | 0.96682217 |
| 113 | MP0003890_abnormal_embryonic-extraembry | 0.94562831 |
| 114 | MP0005448_abnormal_energy_balance | 0.90808419 |
| 115 | MP0003195_calcinosis | 0.89980243 |
| 116 | MP0005310_abnormal_salivary_gland | 0.89546447 |
| 117 | MP0001177_atelectasis | 0.89377572 |
| 118 | MP0002876_abnormal_thyroid_physiology | 0.89248085 |
| 119 | MP0003866_abnormal_defecation | 0.89054342 |
| 120 | MP0005166_decreased_susceptibility_to | 0.88160663 |
| 121 | MP0001346_abnormal_lacrimal_gland | 0.88087861 |
| 122 | MP0002118_abnormal_lipid_homeostasis | 0.87912087 |
| 123 | MP0010386_abnormal_urinary_bladder | 0.87554954 |
| 124 | MP0005410_abnormal_fertilization | 0.86873898 |
| 125 | MP0002069_abnormal_eating/drinking_beha | 0.86609887 |
| 126 | MP0005501_abnormal_skin_physiology | 0.86549245 |
| 127 | MP0003119_abnormal_digestive_system | 0.86332453 |
| 128 | MP0002152_abnormal_brain_morphology | 0.80297332 |
| 129 | MP0005535_abnormal_body_temperature | 0.80249605 |
| 130 | MP0000427_abnormal_hair_cycle | 0.79786982 |
| 131 | MP0010678_abnormal_skin_adnexa | 0.77265333 |
| 132 | MP0001984_abnormal_olfaction | 0.75633587 |
| 133 | MP0008260_abnormal_autophagy | 0.75589701 |
| 134 | MP0004264_abnormal_extraembryonic_tissu | 0.75381164 |
| 135 | MP0006276_abnormal_autonomic_nervous | 0.74932429 |
| 136 | MP0008872_abnormal_physiological_respon | 0.74801770 |
| 137 | MP0002090_abnormal_vision | 0.71808907 |
| 138 | MP0003122_maternal_imprinting | 0.71539556 |
| 139 | MP0004957_abnormal_blastocyst_morpholog | 0.71218691 |
| 140 | MP0000747_muscle_weakness | 0.71071855 |
| 141 | MP0008874_decreased_physiological_sensi | 0.70404227 |
| 142 | MP0001299_abnormal_eye_distance/ | 0.69656203 |
| 143 | MP0003787_abnormal_imprinting | 0.68233251 |
| 144 | MP0001881_abnormal_mammary_gland | 0.68122212 |
| 145 | MP0002938_white_spotting | 0.67958290 |
| 146 | MP0008961_abnormal_basal_metabolism | 0.67313234 |
| 147 | MP0002752_abnormal_somatic_nervous | 0.66699247 |
| 148 | MP0003137_abnormal_impulse_conducting | 0.66361720 |
| 149 | MP0003953_abnormal_hormone_level | 0.64721005 |
| 150 | MP0005174_abnormal_tail_pigmentation | 0.64191161 |
| 151 | MP0000470_abnormal_stomach_morphology | 0.63898618 |
| 152 | MP0004085_abnormal_heartbeat | 0.63074389 |
| 153 | MP0000631_abnormal_neuroendocrine_gland | 0.62939145 |
| 154 | MP0005395_other_phenotype | 0.59738007 |
| 155 | MP0000516_abnormal_urinary_system | 0.58425040 |
| 156 | MP0005367_renal/urinary_system_phenotyp | 0.58425040 |
| 157 | MP0010307_abnormal_tumor_latency | 0.58189412 |
| 158 | MP0001293_anophthalmia | 0.56887491 |
| 159 | MP0002653_abnormal_ependyma_morphology | 0.56653204 |
| 160 | MP0001849_ear_inflammation | 0.55078215 |
| 161 | MP0003567_abnormal_fetal_cardiomyocyte | 0.54183610 |
| 162 | MP0002277_abnormal_respiratory_mucosa | 0.52007914 |
| 163 | MP0009672_abnormal_birth_weight | 0.50907889 |
| 164 | MP0003938_abnormal_ear_development | 0.50162783 |
| 165 | MP0000609_abnormal_liver_physiology | 0.49373836 |
| 166 | MP0002896_abnormal_bone_mineralization | 0.48302965 |
| 167 | MP0000467_abnormal_esophagus_morphology | 0.48150941 |
| 168 | MP0002078_abnormal_glucose_homeostasis | 0.45877901 |
| 169 | MP0002971_abnormal_brown_adipose | 0.45728584 |
| 170 | MP0003937_abnormal_limbs/digits/tail_de | 0.45522202 |
| 171 | MP0009642_abnormal_blood_homeostasis | 0.44984556 |
| 172 | MP0002163_abnormal_gland_morphology | 0.44672249 |
| 173 | MP0000377_abnormal_hair_follicle | 0.44658547 |
| 174 | MP0000383_abnormal_hair_follicle | 0.44079073 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 9.26691539 |
| 2 | Hydroxyprolinuria (HP:0003080) | 6.84685492 |
| 3 | Abnormality of proline metabolism (HP:0010907) | 6.84685492 |
| 4 | Malnutrition (HP:0004395) | 5.55091856 |
| 5 | Myokymia (HP:0002411) | 5.51928163 |
| 6 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 5.31405466 |
| 7 | Abnormality of vitamin B metabolism (HP:0004340) | 5.15520692 |
| 8 | Neurofibrillary tangles (HP:0002185) | 5.11948451 |
| 9 | Focal motor seizures (HP:0011153) | 5.01051845 |
| 10 | Hyperglycinuria (HP:0003108) | 4.75684549 |
| 11 | Supranuclear gaze palsy (HP:0000605) | 4.42012828 |
| 12 | Confusion (HP:0001289) | 4.28340521 |
| 13 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 4.27236499 |
| 14 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 4.27236499 |
| 15 | Abnormality of vitamin metabolism (HP:0100508) | 4.17800060 |
| 16 | Hypobetalipoproteinemia (HP:0003563) | 4.15103162 |
| 17 | Widely patent fontanelles and sutures (HP:0004492) | 4.14950321 |
| 18 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.09082885 |
| 19 | Abnormality of glycine metabolism (HP:0010895) | 4.09082885 |
| 20 | Metabolic alkalosis (HP:0200114) | 4.06897318 |
| 21 | Chronic diarrhea (HP:0002028) | 4.05744260 |
| 22 | Cerebral inclusion bodies (HP:0100314) | 3.97670432 |
| 23 | Fat malabsorption (HP:0002630) | 3.94860815 |
| 24 | Pigmentary retinal degeneration (HP:0001146) | 3.85756082 |
| 25 | Congenital sensorineural hearing impairment (HP:0008527) | 3.76888034 |
| 26 | Ankle clonus (HP:0011448) | 3.75337846 |
| 27 | Action tremor (HP:0002345) | 3.60524991 |
| 28 | Increased circulating renin level (HP:0000848) | 3.56607235 |
| 29 | Acanthocytosis (HP:0001927) | 3.55894280 |
| 30 | Focal seizures (HP:0007359) | 3.52243072 |
| 31 | Abnormality of the corticospinal tract (HP:0002492) | 3.51360159 |
| 32 | Peripheral hypomyelination (HP:0007182) | 3.43544213 |
| 33 | Dysmetria (HP:0001310) | 3.40979552 |
| 34 | Onion bulb formation (HP:0003383) | 3.38018451 |
| 35 | Termporal pattern (HP:0011008) | 3.29309774 |
| 36 | Insidious onset (HP:0003587) | 3.29309774 |
| 37 | Glycosuria (HP:0003076) | 3.29150641 |
| 38 | Abnormality of urine glucose concentration (HP:0011016) | 3.29150641 |
| 39 | Spastic gait (HP:0002064) | 3.28291252 |
| 40 | Abdominal distention (HP:0003270) | 3.26966409 |
| 41 | Intention tremor (HP:0002080) | 3.26152531 |
| 42 | Proximal tubulopathy (HP:0000114) | 3.13037680 |
| 43 | Right ventricular cardiomyopathy (HP:0011663) | 3.09161523 |
| 44 | Pheochromocytoma (HP:0002666) | 3.08659291 |
| 45 | Hepatoblastoma (HP:0002884) | 3.05786507 |
| 46 | Epileptic encephalopathy (HP:0200134) | 3.04355858 |
| 47 | Scanning speech (HP:0002168) | 2.94747734 |
| 48 | Visual hallucinations (HP:0002367) | 2.89846526 |
| 49 | Hypokalemic alkalosis (HP:0001949) | 2.86638391 |
| 50 | Nephrolithiasis (HP:0000787) | 2.86368300 |
| 51 | Abnormal biliary tract morphology (HP:0012440) | 2.84838026 |
| 52 | Abnormality of renin-angiotensin system (HP:0000847) | 2.84365204 |
| 53 | Wide cranial sutures (HP:0010537) | 2.84287035 |
| 54 | Increased purine levels (HP:0004368) | 2.81320854 |
| 55 | Hyperuricemia (HP:0002149) | 2.81320854 |
| 56 | Biliary tract neoplasm (HP:0100574) | 2.81107129 |
| 57 | Megaloblastic anemia (HP:0001889) | 2.78419226 |
| 58 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.77769101 |
| 59 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.74986696 |
| 60 | Villous atrophy (HP:0011473) | 2.74986696 |
| 61 | Hyperactive renin-angiotensin system (HP:0000841) | 2.74682122 |
| 62 | Anxiety (HP:0000739) | 2.73966796 |
| 63 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.71933301 |
| 64 | Posterior subcapsular cataract (HP:0007787) | 2.68760740 |
| 65 | Focal segmental glomerulosclerosis (HP:0000097) | 2.65849224 |
| 66 | Neuroendocrine neoplasm (HP:0100634) | 2.59538081 |
| 67 | Atonic seizures (HP:0010819) | 2.59178191 |
| 68 | Hyperaldosteronism (HP:0000859) | 2.58616671 |
| 69 | Slow saccadic eye movements (HP:0000514) | 2.58392481 |
| 70 | Megalencephaly (HP:0001355) | 2.55998364 |
| 71 | Abnormal auditory evoked potentials (HP:0006958) | 2.55413661 |
| 72 | Dysdiadochokinesis (HP:0002075) | 2.53649399 |
| 73 | Progressive cerebellar ataxia (HP:0002073) | 2.51672241 |
| 74 | Facial shape deformation (HP:0011334) | 2.51374045 |
| 75 | Potter facies (HP:0002009) | 2.51374045 |
| 76 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.48910828 |
| 77 | Urinary urgency (HP:0000012) | 2.48639507 |
| 78 | Depression (HP:0000716) | 2.46053884 |
| 79 | Generalized tonic-clonic seizures (HP:0002069) | 2.45623731 |
| 80 | Abnormal eating behavior (HP:0100738) | 2.44266953 |
| 81 | Flat acetabular roof (HP:0003180) | 2.44132402 |
| 82 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.42396892 |
| 83 | Retinal dysplasia (HP:0007973) | 2.40886439 |
| 84 | Thickened helices (HP:0000391) | 2.40711271 |
| 85 | Truncal ataxia (HP:0002078) | 2.40558753 |
| 86 | Hyperphosphatemia (HP:0002905) | 2.38979567 |
| 87 | Postural instability (HP:0002172) | 2.38488886 |
| 88 | Gout (HP:0001997) | 2.38146158 |
| 89 | Symptomatic seizures (HP:0011145) | 2.36493740 |
| 90 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.36238814 |
| 91 | Dialeptic seizures (HP:0011146) | 2.34529139 |
| 92 | Broad-based gait (HP:0002136) | 2.33124337 |
| 93 | Late onset (HP:0003584) | 2.32042344 |
| 94 | Abnormality of purine metabolism (HP:0004352) | 2.31816611 |
| 95 | Spastic tetraparesis (HP:0001285) | 2.31608345 |
| 96 | Intrahepatic cholestasis (HP:0001406) | 2.31449504 |
| 97 | Steatorrhea (HP:0002570) | 2.28425882 |
| 98 | Cerebral hypomyelination (HP:0006808) | 2.27901810 |
| 99 | Abnormality of potassium homeostasis (HP:0011042) | 2.27090202 |
| 100 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.26757076 |
| 101 | Hypomagnesemia (HP:0002917) | 2.25387975 |
| 102 | Pili torti (HP:0003777) | 2.24803851 |
| 103 | Axonal loss (HP:0003447) | 2.23893174 |
| 104 | Torticollis (HP:0000473) | 2.23659921 |
| 105 | Absence seizures (HP:0002121) | 2.22755423 |
| 106 | Abnormal albumin level (HP:0012116) | 2.22117893 |
| 107 | Hypoalbuminemia (HP:0003073) | 2.22117893 |
| 108 | Neuronal loss in central nervous system (HP:0002529) | 2.20779430 |
| 109 | Clonus (HP:0002169) | 2.17984116 |
| 110 | Clumsiness (HP:0002312) | 2.17319830 |
| 111 | Hypotension (HP:0002615) | 2.15855509 |
| 112 | Retinal atrophy (HP:0001105) | 2.15417842 |
| 113 | Lower limb muscle weakness (HP:0007340) | 2.15176978 |
| 114 | Thin bony cortex (HP:0002753) | 2.12517151 |
| 115 | Poor eye contact (HP:0000817) | 2.11866536 |
| 116 | Nausea (HP:0002018) | 2.09425072 |
| 117 | Diplopia (HP:0000651) | 2.08924517 |
| 118 | Abnormality of binocular vision (HP:0011514) | 2.08924517 |
| 119 | Curly hair (HP:0002212) | 2.08859776 |
| 120 | Hemiparesis (HP:0001269) | 2.07540905 |
| 121 | Abnormal urine phosphate concentration (HP:0012599) | 2.07349415 |
| 122 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.07023649 |
| 123 | Febrile seizures (HP:0002373) | 2.06924640 |
| 124 | Papilledema (HP:0001085) | 2.06469499 |
| 125 | Epidermoid cyst (HP:0200040) | 2.05948232 |
| 126 | Gaze-evoked nystagmus (HP:0000640) | 2.05758582 |
| 127 | Hyperammonemia (HP:0001987) | 2.04768081 |
| 128 | Abnormal pancreas size (HP:0012094) | 2.04724779 |
| 129 | Xanthomatosis (HP:0000991) | 2.03808072 |
| 130 | Hyperventilation (HP:0002883) | 2.03648659 |
| 131 | Hyperphosphaturia (HP:0003109) | 2.03468921 |
| 132 | Chronic bronchitis (HP:0004469) | 2.03299922 |
| 133 | Alacrima (HP:0000522) | 2.01777449 |
| 134 | Impaired social interactions (HP:0000735) | 2.01658767 |
| 135 | Abnormal social behavior (HP:0012433) | 2.01658767 |
| 136 | Decreased circulating renin level (HP:0003351) | 2.01257317 |
| 137 | Aplasia involving bones of the extremities (HP:0009825) | 2.00508979 |
| 138 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.00508979 |
| 139 | Aplasia of the phalanges of the hand (HP:0009802) | 2.00508979 |
| 140 | Abnormality of saccadic eye movements (HP:0000570) | 1.99558564 |
| 141 | Sensory axonal neuropathy (HP:0003390) | 1.99069277 |
| 142 | Cerebral hemorrhage (HP:0001342) | 1.98503336 |
| 143 | Conjugated hyperbilirubinemia (HP:0002908) | 1.98084184 |
| 144 | Hyperparathyroidism (HP:0000843) | 1.94658273 |
| 145 | Abnormality of nucleobase metabolism (HP:0010932) | 1.94523454 |
| 146 | Abnormality of chloride homeostasis (HP:0011422) | 1.94308762 |
| 147 | Glomerulosclerosis (HP:0000096) | 1.93671701 |
| 148 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.93633609 |
| 149 | Hypokalemia (HP:0002900) | 1.93619650 |
| 150 | Hyponatremia (HP:0002902) | 1.93343333 |
| 151 | Focal dystonia (HP:0004373) | 1.93264548 |
| 152 | Limb dystonia (HP:0002451) | 1.92718989 |
| 153 | Subcapsular cataract (HP:0000523) | 1.91754017 |
| 154 | Metabolic acidosis (HP:0001942) | 1.90740345 |
| 155 | Hypophosphatemia (HP:0002148) | 1.90699825 |
| 156 | Dehydration (HP:0001944) | 1.89485553 |
| 157 | Neoplasm of the small intestine (HP:0100833) | 1.88977047 |
| 158 | Ileus (HP:0002595) | 1.88345014 |
| 159 | Ventricular fibrillation (HP:0001663) | 1.87161617 |
| 160 | Impulsivity (HP:0100710) | 1.86822732 |
| 161 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 1.86248141 |
| 162 | Craniofacial dystonia (HP:0012179) | 1.86067289 |
| 163 | Abnormality of magnesium homeostasis (HP:0004921) | 1.85712324 |
| 164 | Rigidity (HP:0002063) | 1.85554443 |
| 165 | Split foot (HP:0001839) | 1.85375862 |
| 166 | Abnormality of serum amino acid levels (HP:0003112) | 1.85254524 |
| 167 | Mutism (HP:0002300) | 1.84747325 |
| 168 | Psychosis (HP:0000709) | 1.84556095 |
| 169 | Foot dorsiflexor weakness (HP:0009027) | 1.84333340 |
| 170 | CNS hypomyelination (HP:0003429) | 1.83490857 |
| 171 | Hypoglycemic seizures (HP:0002173) | 1.82582313 |
| 172 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 1.82002885 |
| 173 | Renal tubular acidosis (HP:0001947) | 1.81515364 |
| 174 | Abnormal glucose tolerance (HP:0001952) | 1.80064537 |
| 175 | Leukodystrophy (HP:0002415) | 1.79837533 |
| 176 | Alkalosis (HP:0001948) | 1.79196598 |
| 177 | Epileptiform EEG discharges (HP:0011182) | 1.79021607 |
| 178 | Choreoathetosis (HP:0001266) | 1.78817639 |
| 179 | EEG with generalized epileptiform discharges (HP:0011198) | 1.78617479 |
| 180 | Neoplasm of the rectum (HP:0100743) | 1.77602612 |
| 181 | Hyperglycinemia (HP:0002154) | 1.77102527 |
| 182 | Cerebral palsy (HP:0100021) | 1.76357813 |
| 183 | Delayed epiphyseal ossification (HP:0002663) | 1.75989915 |
| 184 | Hypolipoproteinemia (HP:0010981) | 1.75226630 |
| 185 | Dicarboxylic aciduria (HP:0003215) | 1.75069598 |
| 186 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.75069598 |
| 187 | Irritability (HP:0000737) | 1.72874354 |
| 188 | Bronchomalacia (HP:0002780) | 1.72763140 |
| 189 | Hyperkalemia (HP:0002153) | 1.72354985 |
| 190 | Chorioretinal atrophy (HP:0000533) | 1.71760289 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ACVR1B | 7.10209632 |
| 2 | EPHA2 | 4.49201035 |
| 3 | STK39 | 3.71496522 |
| 4 | EPHA4 | 3.40584837 |
| 5 | OXSR1 | 3.11919678 |
| 6 | MAP3K10 | 2.93590726 |
| 7 | NTRK3 | 2.89214496 |
| 8 | RIPK1 | 2.76199002 |
| 9 | MAP3K9 | 2.68408430 |
| 10 | KSR2 | 2.36194440 |
| 11 | MAPKAPK5 | 2.28509062 |
| 12 | WNK4 | 2.20655254 |
| 13 | NTRK1 | 2.11445021 |
| 14 | FRK | 2.00813612 |
| 15 | PRKD3 | 2.00569316 |
| 16 | EPHB2 | 1.98566741 |
| 17 | EPHB1 | 1.94031999 |
| 18 | WNK1 | 1.91355587 |
| 19 | STK24 | 1.85183152 |
| 20 | UHMK1 | 1.77908954 |
| 21 | MAP3K2 | 1.77016651 |
| 22 | SGK223 | 1.75088136 |
| 23 | SGK494 | 1.75088136 |
| 24 | PNCK | 1.72950181 |
| 25 | NLK | 1.66984405 |
| 26 | PAK6 | 1.65196963 |
| 27 | CAMK2B | 1.60860943 |
| 28 | MAP3K4 | 1.54525631 |
| 29 | ARAF | 1.54357563 |
| 30 | EPHA3 | 1.51438257 |
| 31 | BCR | 1.49128842 |
| 32 | CDK19 | 1.48078204 |
| 33 | MARK1 | 1.45963026 |
| 34 | RIPK4 | 1.45303694 |
| 35 | PKN1 | 1.45297601 |
| 36 | MINK1 | 1.44008553 |
| 37 | ERN1 | 1.42462894 |
| 38 | MAP3K13 | 1.41919368 |
| 39 | CAMK2D | 1.40988272 |
| 40 | CDK5 | 1.38894518 |
| 41 | PTK6 | 1.37904172 |
| 42 | DAPK2 | 1.36060141 |
| 43 | LIMK1 | 1.34555570 |
| 44 | MKNK2 | 1.33867971 |
| 45 | STK38L | 1.32803765 |
| 46 | NTRK2 | 1.28131034 |
| 47 | NEK6 | 1.26897213 |
| 48 | MET | 1.25790085 |
| 49 | MST4 | 1.20832449 |
| 50 | FGFR2 | 1.19953863 |
| 51 | CAMK2G | 1.17309129 |
| 52 | TTK | 1.16744085 |
| 53 | FGFR4 | 1.14015334 |
| 54 | GRK1 | 1.11880268 |
| 55 | CAMK2A | 1.07727861 |
| 56 | LMTK2 | 1.07619231 |
| 57 | MAP2K7 | 1.06821901 |
| 58 | CAMKK1 | 1.06615951 |
| 59 | STK3 | 1.02434164 |
| 60 | MAP3K1 | 0.99974879 |
| 61 | LATS1 | 0.99558457 |
| 62 | ERBB2 | 0.97884711 |
| 63 | TYRO3 | 0.96853431 |
| 64 | PAK3 | 0.96813520 |
| 65 | NUAK1 | 0.95758358 |
| 66 | TNIK | 0.95412624 |
| 67 | ROCK2 | 0.90910609 |
| 68 | PRKCH | 0.90281969 |
| 69 | CASK | 0.88374148 |
| 70 | MAPK15 | 0.85729369 |
| 71 | FES | 0.84383724 |
| 72 | PDPK1 | 0.82713720 |
| 73 | PINK1 | 0.80137955 |
| 74 | PHKG2 | 0.80084260 |
| 75 | PHKG1 | 0.80084260 |
| 76 | CDK14 | 0.79925965 |
| 77 | CDK15 | 0.79526554 |
| 78 | INSRR | 0.76583181 |
| 79 | PRKCE | 0.76173721 |
| 80 | PRPF4B | 0.76033445 |
| 81 | CDK18 | 0.75809436 |
| 82 | STK11 | 0.75638451 |
| 83 | AKT3 | 0.74366912 |
| 84 | MARK2 | 0.73991689 |
| 85 | CSNK1G2 | 0.73724563 |
| 86 | BMPR2 | 0.73696954 |
| 87 | GRK5 | 0.73374511 |
| 88 | MKNK1 | 0.71669092 |
| 89 | MAP2K4 | 0.71587150 |
| 90 | TSSK6 | 0.71043960 |
| 91 | CAMKK2 | 0.70552771 |
| 92 | CDK11A | 0.68994229 |
| 93 | MST1R | 0.68352927 |
| 94 | MAP2K2 | 0.67906381 |
| 95 | PTK2 | 0.67225605 |
| 96 | MUSK | 0.65853288 |
| 97 | FYN | 0.63042651 |
| 98 | BRSK2 | 0.62729864 |
| 99 | PRKD1 | 0.62674557 |
| 100 | SGK1 | 0.61960164 |
| 101 | CSNK1G3 | 0.61911500 |
| 102 | PDK1 | 0.61829278 |
| 103 | CSNK1A1L | 0.61739474 |
| 104 | IRAK1 | 0.61247887 |
| 105 | FGR | 0.60871916 |
| 106 | WNK3 | 0.60133637 |
| 107 | RET | 0.59561257 |
| 108 | TAOK3 | 0.57657241 |
| 109 | MAPK13 | 0.56867458 |
| 110 | PRKCZ | 0.56068120 |
| 111 | HIPK2 | 0.55433784 |
| 112 | NME1 | 0.55323586 |
| 113 | CSNK1A1 | 0.54874384 |
| 114 | CAMK1G | 0.54103001 |
| 115 | DYRK2 | 0.53947189 |
| 116 | CDC42BPA | 0.53918432 |
| 117 | YES1 | 0.53799261 |
| 118 | PRKG2 | 0.53100023 |
| 119 | PRKCG | 0.52722011 |
| 120 | ZAK | 0.52663968 |
| 121 | DMPK | 0.51250573 |
| 122 | KSR1 | 0.50616490 |
| 123 | FGFR1 | 0.50593927 |
| 124 | FER | 0.50438960 |
| 125 | DYRK1B | 0.50254865 |
| 126 | PRKCQ | 0.50217196 |
| 127 | PDK2 | 0.49890997 |
| 128 | PRKAA2 | 0.49647678 |
| 129 | PRKCA | 0.49620064 |
| 130 | ALK | 0.49080808 |
| 131 | MATK | 0.49005669 |
| 132 | MAP2K1 | 0.48683282 |
| 133 | PRKACG | 0.48422278 |
| 134 | SGK3 | 0.48329712 |
| 135 | MELK | 0.48323130 |
| 136 | PIK3CA | 0.47756257 |
| 137 | CAMK1 | 0.47689628 |
| 138 | CLK1 | 0.44531676 |
| 139 | PAK4 | 0.43778632 |
| 140 | BMX | 0.43031854 |
| 141 | MAP3K12 | 0.42853096 |
| 142 | PRKCI | 0.42428202 |
| 143 | STK16 | 0.41936550 |
| 144 | TRIM28 | 0.40117400 |
| 145 | TAOK1 | 0.40003288 |
| 146 | FGFR3 | 0.35363281 |
| 147 | BMPR1B | 0.35247547 |
| 148 | MAP2K6 | 0.33146573 |
| 149 | ADRBK2 | 0.32206243 |
| 150 | SRC | 0.31504789 |
| 151 | DDR2 | 0.30930669 |
| 152 | NEK2 | 0.27998862 |
| 153 | NEK1 | 0.27208627 |
| 154 | MYLK | 0.24986624 |
| 155 | IGF1R | 0.24654083 |
| 156 | DYRK3 | 0.24531795 |
| 157 | TAF1 | 0.24151673 |
| 158 | PLK3 | 0.22683780 |
| 159 | CSNK1E | 0.22029067 |
| 160 | ERBB4 | 0.21862671 |
| 161 | DAPK1 | 0.21024731 |
| 162 | PIM1 | 0.20973723 |
| 163 | PRKACA | 0.18696075 |
| 164 | PLK1 | 0.18542905 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 5.09268377 |
| 2 | Fat digestion and absorption_Homo sapiens_hsa04975 | 4.10816909 |
| 3 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 4.02866678 |
| 4 | Renin-angiotensin system_Homo sapiens_hsa04614 | 3.60368815 |
| 5 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.64376486 |
| 6 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.61203440 |
| 7 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.59933006 |
| 8 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 2.45070353 |
| 9 | GABAergic synapse_Homo sapiens_hsa04727 | 2.40995969 |
| 10 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.35450698 |
| 11 | Protein digestion and absorption_Homo sapiens_hsa04974 | 2.34373091 |
| 12 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.30275513 |
| 13 | Nicotine addiction_Homo sapiens_hsa05033 | 2.20732987 |
| 14 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.18058979 |
| 15 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.13861560 |
| 16 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 2.13104255 |
| 17 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.04313008 |
| 18 | Circadian entrainment_Homo sapiens_hsa04713 | 2.02970433 |
| 19 | Retinol metabolism_Homo sapiens_hsa00830 | 2.01798420 |
| 20 | Morphine addiction_Homo sapiens_hsa05032 | 2.01277376 |
| 21 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.99105670 |
| 22 | Olfactory transduction_Homo sapiens_hsa04740 | 1.95715591 |
| 23 | Salivary secretion_Homo sapiens_hsa04970 | 1.91746112 |
| 24 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.91425703 |
| 25 | Galactose metabolism_Homo sapiens_hsa00052 | 1.88464427 |
| 26 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.88051941 |
| 27 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.83783553 |
| 28 | Cocaine addiction_Homo sapiens_hsa05030 | 1.81761019 |
| 29 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.80951747 |
| 30 | Insulin secretion_Homo sapiens_hsa04911 | 1.79669679 |
| 31 | Long-term potentiation_Homo sapiens_hsa04720 | 1.79492370 |
| 32 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.78817566 |
| 33 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.73168153 |
| 34 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.62998339 |
| 35 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.62089329 |
| 36 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.61810939 |
| 37 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.56376202 |
| 38 | Long-term depression_Homo sapiens_hsa04730 | 1.54349714 |
| 39 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.53819753 |
| 40 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.53093637 |
| 41 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.51087333 |
| 42 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.50015262 |
| 43 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.49961079 |
| 44 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.49062569 |
| 45 | Renin secretion_Homo sapiens_hsa04924 | 1.47458524 |
| 46 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.47072955 |
| 47 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.43926341 |
| 48 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.40255748 |
| 49 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.38792016 |
| 50 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.38728163 |
| 51 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.35822461 |
| 52 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.34757703 |
| 53 | Taste transduction_Homo sapiens_hsa04742 | 1.34011937 |
| 54 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.33961317 |
| 55 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.30385943 |
| 56 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.29013390 |
| 57 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.28865376 |
| 58 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.27392293 |
| 59 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.26837360 |
| 60 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.24249054 |
| 61 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.24119543 |
| 62 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.23875896 |
| 63 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.21294884 |
| 64 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.11921162 |
| 65 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.10787763 |
| 66 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.08088872 |
| 67 | Mineral absorption_Homo sapiens_hsa04978 | 1.07625718 |
| 68 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.05745061 |
| 69 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.04087172 |
| 70 | Gap junction_Homo sapiens_hsa04540 | 1.03391576 |
| 71 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.02867691 |
| 72 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.02573915 |
| 73 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.00748043 |
| 74 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.99055287 |
| 75 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.97091438 |
| 76 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.93583733 |
| 77 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.93121757 |
| 78 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.92661371 |
| 79 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.90685361 |
| 80 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.90643931 |
| 81 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.90563890 |
| 82 | Axon guidance_Homo sapiens_hsa04360 | 0.89775175 |
| 83 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.89726227 |
| 84 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.89049495 |
| 85 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.88938607 |
| 86 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.85349413 |
| 87 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.83417344 |
| 88 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.81750603 |
| 89 | Bile secretion_Homo sapiens_hsa04976 | 0.79575196 |
| 90 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.78755743 |
| 91 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.78545802 |
| 92 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.75600812 |
| 93 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.75340411 |
| 94 | Histidine metabolism_Homo sapiens_hsa00340 | 0.75150527 |
| 95 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.74035908 |
| 96 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.73800212 |
| 97 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.71918470 |
| 98 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.70871207 |
| 99 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.70493865 |
| 100 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.69281728 |
| 101 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.69153008 |
| 102 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.68265978 |
| 103 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.67927882 |
| 104 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.67908585 |
| 105 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.67678532 |
| 106 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.66476706 |
| 107 | * Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.65375492 |
| 108 | Alzheimers disease_Homo sapiens_hsa05010 | 0.63885444 |
| 109 | Melanogenesis_Homo sapiens_hsa04916 | 0.63195175 |
| 110 | Lysosome_Homo sapiens_hsa04142 | 0.62462747 |
| 111 | Endocytosis_Homo sapiens_hsa04144 | 0.62166800 |
| 112 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.61801968 |
| 113 | Peroxisome_Homo sapiens_hsa04146 | 0.61674432 |
| 114 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.59927275 |
| 115 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.58519478 |
| 116 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.58245683 |
| 117 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.57662666 |
| 118 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.56298123 |
| 119 | Tight junction_Homo sapiens_hsa04530 | 0.55739451 |
| 120 | Prion diseases_Homo sapiens_hsa05020 | 0.55494114 |
| 121 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.55407236 |
| 122 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.53189728 |
| 123 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.52901511 |
| 124 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.52802634 |
| 125 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.52155599 |
| 126 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.51199459 |
| 127 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.48435974 |
| 128 | Glioma_Homo sapiens_hsa05214 | 0.47570285 |
| 129 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.46076071 |
| 130 | Parkinsons disease_Homo sapiens_hsa05012 | 0.44379227 |
| 131 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.44054577 |
| 132 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.42561286 |
| 133 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.41324495 |
| 134 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.39748004 |
| 135 | Phototransduction_Homo sapiens_hsa04744 | 0.38875168 |
| 136 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.38035034 |
| 137 | Protein export_Homo sapiens_hsa03060 | 0.36643876 |
| 138 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.35906709 |
| 139 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.35387261 |
| 140 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.34522278 |
| 141 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.33617309 |
| 142 | ABC transporters_Homo sapiens_hsa02010 | 0.32141504 |
| 143 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.30728519 |
| 144 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.29941589 |
| 145 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.28124681 |
| 146 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.27978359 |
| 147 | Asthma_Homo sapiens_hsa05310 | 0.27880907 |
| 148 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.27285659 |
| 149 | Sulfur relay system_Homo sapiens_hsa04122 | 0.25652407 |
| 150 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.25601835 |
| 151 | Adherens junction_Homo sapiens_hsa04520 | 0.24377774 |
| 152 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.23179237 |
| 153 | Carbon metabolism_Homo sapiens_hsa01200 | 0.18700079 |
| 154 | Insulin resistance_Homo sapiens_hsa04931 | 0.17006142 |
| 155 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.16652281 |
| 156 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.14441473 |
| 157 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.11920061 |
| 158 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.09483061 |
| 159 | Hepatitis C_Homo sapiens_hsa05160 | 0.01180036 |

